COMMUNIQUÉ DE PRESSE publié le 17/01/2024 à 15:00, il y a 1 année 10 mois Chiron AS Establishes State-of-the-Art Research Centre in Trondheim, Norway, Advancing Environmental Surveillance Chiron AS, a leading producer of chemical reference materials, has announced the establishment of a state-of-the-art research centre dedicated to enhanced surveillance of environmental pollutants, supported by a significant investment. The new facility is equipped to address challenging pollutants like microplastics and PFAS, and follows Chiron's acquisition by Antylia Scientific, aligning with the ZeptoMetrix Reference Material and Proficiency Testing portfolio. This development reaffirms Chiron's commitment to scientific excellence and supports its mission to protect humans from undesired chemical exposure. Chiron AS Environmental Pollutants Research Centre Chemical Reference Materials ZeptoMetrix
COMMUNIQUÉ DE PRESSE publié le 03/10/2023 à 15:00, il y a 2 années 2 mois ZeptoMetrix Awarded in Vitro Diagnostic Regulation (IVDR) Certification
COMMUNIQUÉ DE PRESSE publié le 16/05/2023 à 15:00, il y a 2 années 6 mois ZeptoMetrix Launches PROtrol: Quality Control Material for the Lateral Flow Immunoassay Market
Publié le 04/12/2025 à 18:14, il y a 13 heures 35 minutes Résiliation d'une convention conclue entre actionnaires
Publié le 04/12/2025 à 18:00, il y a 13 heures 50 minutes Informations relatives au nombre total de droits de vote et d’actions composant le capital social au 28 novembre 2025
Publié le 04/12/2025 à 18:00, il y a 13 heures 50 minutes Information concerning the total number of voting rights and shares in the share capital as of November 28, 2025
Publié le 04/12/2025 à 17:45, il y a 14 heures 5 minutes Informations relatives au nombre total de droits de vote et d’actions
Publié le 04/12/2025 à 17:45, il y a 14 heures 5 minutes MONTHLY INFORMATION RELATING TO THE TOTAL NUMBER OF VOTING RIGHTS AND SHARES MAKING UP THE SHARE CAPITAL
Publié le 05/12/2025 à 02:35, il y a 5 heures 15 minutes Future Fuels Initates Drill Permitting at Hornby; Marketing Update
Publié le 05/12/2025 à 01:00, il y a 6 heures 50 minutes BEACN Closes First Tranche of Non-Brokered Private Placement
Publié le 04/12/2025 à 23:05, il y a 8 heures 45 minutes BlackBerry to Announce Third Quarter Fiscal Year 2026 Results on December 18, 2025
Publié le 04/12/2025 à 23:00, il y a 8 heures 50 minutes NXT Energy Solutions Completes Data Acquisition for SFD Survey
Publié le 05/12/2025 à 07:00, il y a 49 minutes Swiss Re targets a net income of USD 4.5 billion in 2026; refreshed strategy to strengthen core business
Publié le 05/12/2025 à 03:30, il y a 4 heures 19 minutes CGTN: What makes cooperation between China and France a two-way success
Publié le 04/12/2025 à 23:50, il y a 7 heures 59 minutes EQS-Adhoc: Dexus Finance Pty Limited: Dexus prices A$500 million of subordinated notes
Publié le 04/12/2025 à 20:25, il y a 11 heures 24 minutes Newmark Appoints Globally Recognized Real Estate Executive Peter Trollope to Lead Occupier Solutions
Publié le 04/12/2025 à 20:15, il y a 11 heures 35 minutes Galimedix Therapeutics presents compelling Phase 1 study results showing excellent safety and pharmacokinetics with oral small molecule GAL-101 at CTAD 2025
